Our Pipeline

Vita aims to be a global leader in cell engineering through successful completion of clinical trials for its pipeline of programs leveraging platforms in both neuromuscular and immunotherapy.

Clinical Trials

Vita Therapeutics will soon be recruiting 15 patients for a first-in-human (FIH) clinical trial of VTA-100. Please monitor this site for more details on the trial and timing.

Interested in Participating?

801 W. Baltimore St.
STE 301
Baltimore, MD 21201

About UsOverviewLeadership TeamBoard of DirectorsScientific Co-FoundersScientific Advisory BoardOur TechnologyOverviewAutologous ApproachAllogeneic ApproachCareers
PipelineOverviewLGMD2AFSHDClinical TrialsNewsroomTop NewsPublicationsIn the NewsMedia InquiriesGet in Touch
Terms and Conditions
Privacy Policy
Cookies
Social Media
© 2022 Vita Therapeutics, Inc. All rights reserved